Pliant Therapeutics Inc. (PLRX) Social Stream



Pliant Therapeutics Inc. (PLRX): $18.23

-0.15 (-0.82%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PLRX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 380

in industry

PLIANT THERAPEUTICS INC (PLRX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering PLIANT THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 4 $63 $45 $52.75 $19.51 170.37%
2021-11-24 5 $63 $38 $49.8 $19.51 155.25%
2022-03-01 6 $63 $38 $48.166 $19.51 146.88%
2022-05-11 5 $63 $38 $46.5 $19.51 138.34%
2022-05-18 5 $45 $27 $37.5 $19.51 92.21%
2022-06-01 6 $45 $27 $35.6 $19.51 82.47%
2022-07-26 7 $54 $33 $42 $19.51 115.27%
2022-08-11 7 $54 $33 $43.833 $19.51 124.67%
2022-09-01 8 $54 $33 $42.714 $19.51 118.93%
2022-11-18 8 $53 $33 $42.142 $19.51 116%

The Trend in the Analyst Price Target


PLRX's average price target has moved down $1.19 over the prior 20 months.

Over the past 51 weeks, PLRX's average upside potential has been 403.05%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-01 6 63 38 46.500 10.01 364.54%
2022-03-01 5 63 38 48.166 10.01 381.18%
2022-05-09 5 63 38 46.500 4.46 942.6%
2022-07-26 7 54 33 42.000 17.64 138.1%
2022-09-01 8 54 33 42.714 20.30 110.41%

PLRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.13 7 1 0 0 0 8

The Trend in the Broker Recommendations


PLRX's average broker recommendation rating improved by 0.08 over the prior 26 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, PLIANT THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 971.47% of them.
  • In terms of how PLIANT THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 426.26% of that group.
  • In the context of stocks in the small market cap category, PLIANT THERAPEUTICS INC's average analyst price target is greater than 1126.53% of them.
  • In the context of Pharmaceutical Products stocks, PLIANT THERAPEUTICS INC's variance in analysts' estimates is lower than -371.29% of them.

In the Pharmaceutical Products industry, CALT, RNA, and GBIO are the three stocks most similar to PLIANT THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is PLRX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5945 seconds.